Sign in
Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy
Jeffrey S. Heier, MD
Annual Meeting Talks
2022
Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results
Peter J. Kertes, MD, FRCS(C)
2019
Category: Dry AMD